Development
Antiaging Quantum Living Inc.
AAQL
$0.60
-$0.40-40.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 57.50% | -- | -50.00% | -50.00% | 185.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.50% | -- | -50.00% | 50.00% | 185.71% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 37.50% | -- | -50.00% | 50.00% | 344.44% |
| SG&A Expenses | 850.00% | 225.33% | 31.49% | 37.70% | -46.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 857.41% | 225.33% | 31.49% | 37.70% | -47.83% |
| Operating Income | -1,327.94% | -1,526.67% | -40.76% | -38.46% | 64.77% |
| Income Before Tax | -1,327.94% | -1,526.67% | -40.76% | -94.59% | 64.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,327.94% | -1,526.67% | -40.76% | -94.59% | 64.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,327.94% | -1,526.67% | -40.76% | -94.59% | 64.77% |
| EBIT | -1,327.94% | -1,526.67% | -40.76% | -38.46% | 64.77% |
| EBITDA | -1,347.76% | -1,635.71% | -40.95% | -38.46% | 65.28% |
| EPS Basic | -1,500.00% | -700.00% | -42.86% | -100.00% | 66.67% |
| Normalized Basic EPS | -1,900.00% | -- | -50.00% | -100.00% | 75.00% |
| EPS Diluted | -1,500.00% | -700.00% | -42.86% | -100.00% | 66.67% |
| Normalized Diluted EPS | -1,900.00% | -- | -50.00% | -100.00% | 75.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |